Enabling innovation in cell and gene therapy

Expertise

In the news

dna-g624eb8017_1920 gerd altmann pixabay.jpg

Development
of new Gene Therapies

Lentiviral vector production

Time to Evolve: Predicting engineered T cell toxicity with next gen. models

ART-TG contributed to this recent review by Donnadieu et al. in Journal for Immunotherapy of Cancer, https://jitc.bmj.com/content/10/5/e0...

ART-TG recruits

ART-TG recruits engineers and managers for its projects. Please check the JOBS annoucements

SEE MORE INFORMATION

About us

ART-TG is an innovation and development laboratory for cell and gene therapy, established by Inserm. Its mission is to accelerate the transfer of promising research discoveries towards clinical stages, which ultimately will ensure that the best gene therapies will be available for patients.

Anne Galy, founder of ART-TG (view her bio)

ART-TG is a founding member of the MAGENTA industrial integrator, established by the French government to address the challenges of industrial production of biomedecines.